JOE MCAMIS: Open Payments
NPI 1497898548 · FT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 89 payments from 5 companies in 2025. Trend: 2023 $328 · 2024 $251 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 46 | $387 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $239 |
| Otsuka America Pharmaceutical, Inc. | 15 | $150 |
| Alkermes, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, CAPLYTA, REXULTI, ARISTADA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
